论文信息 - A phase III study comparing SB8, a proposed bevacizumab biosimilar, and reference bevacizumab in patients with metastatic or recurrent non-squamous NSCLC - 字舞流文

A phase III study comparing SB8, a proposed bevacizumab biosimilar, and reference bevacizumab in patients with metastatic or recurrent non-squamous NSCLC

I. Bondarenko | M. Reck | N. Kovalenko | Donghoon Shin | A. Luft | D. Trukhin | K. Vacharadze | Jihye Choi | F. Andrea | A. Hontsa | Serhii Shevnia